Discover how AAV-based gene therapy delivers anti-eosinophil antibodies, offering hope for chronic hypereosinophilia ...

A study published in Human Gene Therapy has involved the generation of a human monoclonal antibody (mAb) directed against ...

Treatments for rare diseases are hard to create and expensive to deliver, but there is new hope for editing the software of ...

Mitochondrial genetics and metabolism are deeply involved in cancer progression—from aiding cell motility and invasion to ...

New research by Oregon Health & Science University scientists has uncovered multiple factors to improve gene delivery to the ...

and other AAV serotypes to identify novel capsids optimized for AAV delivery for specific therapeutic applications. Voyager’s next-generation capsids are designed to deliver innovative AAV-based ...

That said, vectors based on natural versions of AAV face a number of delivery challenges that limit their efficacy and will thus preclude the extension of these successes to the majority of human ...

Adeno-associated virus (AAV) vectors are at the forefront of gene therapy, revolutionizing treatments for genetic disorders. With their increasing adoption, precise tools are vital for quantifying AAV ...

Gene therapy has experienced an increasing number of successful human clinical trials, leading to 6 FDA approved products using delivery vectors based on adeno-associated viruses (AAV). These ...